BamSEC and AlphaSense Join Forces
Learn More

BioNexus Gene Lab Corp – Material Contracts

NASDAQ: BGLC    
Share price (6/4/26): $2.29    
Market cap (6/4/26): $5.548 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.2
from 8-K 19 pages Exclusive Intellectual Property License Agreement (Southeast Asia) by and Between Fidelion Diagnostics Pte. Ltd. (As Licensor) and BioNexus Gene Lab Corp. (As Licensee) Dated as of November 28, 2025
12/34/56
EX-10.1
from 8-K 35 pages Purchase Agreement
12/34/56
EX-10.1
from 8-K 22 pages Share Subscription and Shareholders’ Agreement in Respect of Fidelion Diagnostics Pte. Ltd. (Company Registration No. 202527265w) Dated: November 12, 2025
12/34/56
EX-10.2
from S-3 4 pages BioNexus Gene Lab Corporation BioNexus Gene Lab Sdn Bhd 203 S Main Street Ste 3000, Wyoming 82801, USA Tel: +60122126512 10-2, Tower B, Vertical Business Suite II, Avenue 3, Bangsar South, 8 Jalan Kerinchi 59200 Kuala Lumpur, Malaysia Tel: 03-74940760
12/34/56
EX-10.8
from 10-Q 6 pages BioNexus Gene Lab Corp. Form of Non‑qualified Stock Option Agreement 1. Grant of Option
12/34/56
EX-10.7
from 8-K 7 pages Mrna Scientific Sdn Bhd A-28-07 Menara Uoa Bangsar No. 5 Jalan Bangsar Utama 1 Kuala Lumpur, Malaysia 59000 Private & Confidential [By Hand] 17 June 2025 Chong Set Fui (Angeline) Dear Mrs. Chong, Letter of Employment – Chief Financial Officer We Are Pleased to Offer You Employment in Mrna Scientific Sdn Bhd (The “Company”) According to the Following Terms and Conditions
12/34/56
EX-10.5
from 10-K 4 pages Re: Director Offer Letter – Jook Yuen Low
12/34/56
EX-10.4
from 10-K 4 pages Re: Director Offer Letter – Muhammad Azrul Bin Abdul Hamid
12/34/56
EX-10.3
from 10-K 4 pages Re: Director Offer Letter – Su-Leng Tan Lee
12/34/56
EX-10.1
from 8-K 3 pages Teaming Agreement Between Mrna Scientific Sdn. Bhd. and Protech Builders Sdn. Bhd. for Biogas Plant Development This Teaming Agreement (“Agreement”) Is Made on September 23, 2024 Between
12/34/56
EX-10.1
from 8-K 42 pages This Shareholders Agreement Is Made on 23rd August 2024 Amongst (1) the Existing Shareholders Whose Names and Particulars Are as Set Out in Schedule 1; (2) the Crowdfunding Direct Shareholders Whose Names and Particulars Are Set Out in Schedule 2; (3) the Nominee Whose Name and Particulars Are Set Out in Schedule 3; (“The Existing Shareholders, the Crowdfunding Direct Shareholders and the Nominee Shall Hereinafter Be Collectively Referred to as “The Shareholders”) and (4) the Company Whose Corporate Details Are Set Out in Schedule 4. Recitals
12/34/56
EX-10.1
from 8-K/A 2 pages Date: June 30, 2024 Mr. Su-Leng Tan Lee C2-2-8 Megan Phoenix Off Jalan Cheras Kuala Lumpur, Malaysia Dear Mr. Tan Lee, Re: Amendment to Service Contract, Recognition as Chief Executive Officer and Acting Chief Financial Officer
12/34/56
EX-10.1
from S-1/A 37 pages Share Exchange Agreement
12/34/56
EX-10.11
from S-1/A 4 pages BioNexus Gene Lab Corp. Unit 02, Level 10, Tower B, Vertical Business Suite Bangsar South, 8 Jalan Kerinchi 59200 Kuala Lumpur Malaysia
12/34/56
EX-10.10
from S-1/A 4 pages BioNexus Gene Lab Corp. Unit 02, Level 10, Tower B, Vertical Business Suite Bangsar South, 8 Jalan Kerinchi 59200 Kuala Lumpur Malaysia
12/34/56
EX-10.9
from S-1/A 4 pages BioNexus Gene Lab Corp. Unit 02, Level 10, Tower B, Vertical Business Suite Bangsar South, 8 Jalan Kerinchi 59200 Kuala Lumpur Malaysia
12/34/56
EX-10.8
from S-1/A 4 pages BioNexus Gene Lab Corp. Unit 02, Level 10, Tower B, Vertical Business Suite Bangsar South, 8 Jalan Kerinchi 59200 Kuala Lumpur Malaysia
12/34/56
EX-10.7
from S-1/A 4 pages BioNexus Gene Lab Corp. Unit 02, Level 10, Tower B, Vertical Business Suite Bangsar South, 8 Jalan Kerinchi 59200 Kuala Lumpur Malaysia
12/34/56
EX-10.6
from S-1/A 1 page BioNexus Gene Lab Corporation BioNexus Gene Lab Sdn Bhd 203 S Main Street Ste 3000, Wyoming 82801, USA Tel: +60122126512 10-2, Tower B, Vertical Business Suite II, Avenue 3, Bangsar South City, 8 Jalan Kerinchi 59200 Kuala Lumpur, Malaysia Tel: 03-74940760 Date: Nov 27, 2020 Mr Liong Tai Tan 56 Jalan Bakau, Kepong Baru Kuala Lumpur Malaysia Dear Mr Tan Chief Operating Officer/Board Member
12/34/56
EX-10.5
from S-1/A 4 pages BioNexus Gene Lab Corporation BioNexus Gene Lab Sdn Bhd 203 S Main Street Ste 3000, Wyoming 82801, USA Tel: +60122126512 10-2, Tower B, Vertical Business Suite, Avenue 3, Bangsar South City, 8 Jalan Kerinchi, 59200 Kuala Lumpur, Malaysia Tel: 03-74940760
12/34/56